Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 12:05 AM
NCT ID:
NCT00115258
Eligibility Criteria:
Inclusion Criteria:
* First myeloablative allogeneic SCT using either TBI (1400 cGy) or busulfan in addition to other chemotherapeutic agents
* GVHD prophylaxis with a calcineurin-inhibitor and methotrexate +/- corticosteroids
* Matched, related or 6/6 HLA-matched unrelated SCT donor
* Age 6 years and older
Exclusion Criteria:
* Age less than 6 years, or otherwise unable to comply with study procedures
* Underweight (body mass index (BMI) z-score \<2 for age and sex) at baseline
* Overweight (BMI z-score \>2 for age and sex) at baseline
* Unable or unwilling to return for day + 100 studies
* Previous stem cell transplant
* Unmatched SCT donor
* Current treatment for hypo- or hyperthyroidism
* Current insulin dependent diabetes
* Current use of parenteral nutrition
* Allergy to egg or soy products
* Other contraindication to parenteral nutrition at baseline
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Study:
NCT00115258
Study Brief:
Protocol Section:
NCT00115258